ABSTRACT N, increases agonist affinities. Agonist displacement curves are biphasic, probably reflecting the G protein-coupled and uncoupled states of the receptor. The proportion of the high-affinity component is increased by GS39783, suggesting that the G protein coupling of the receptor is also promoted by the positive modulator. We also show that GS39783 has modulatory effects in cellular assays such as GABA B receptor-mediated activation of inwardly rectifying potassium channels in Xenopus oocytes and Ca 2ϩ signaling in human embryonic kidney 293 cells. In a more physiological context, GS39783 is shown to suppress paired pulse inhibition in rat hippocampal slices. This effect is reversed by the competitive GABA B receptor antagonist CGP55845A and is produced most likely by enhancing the effect of synaptically released GABA at presynaptic GABA B receptors.
S]GTP␥S binding by themselves. Similar effects of GS39783 are seen on native GABA B receptors in rat brain membranes. Concentrationresponse curves with GABA in the presence of different fixed concentrations of GS39783 reveal an increase of both the potency and maximal efficacy of GABA at the GABA B(1b/2) heterodimer. In radioligand binding experiments, GS39783 reduces the kinetic rate constants of the association and dissociation of [ 3 H]3-aminopropylphosphinic acid, resulting in a net increase in affinity for the agonist radioligand. In equilibrium binding experiments (displacement of the antagonist ligand [ 3 H]CGP62349), GS39783 increases agonist affinities. Agonist displacement curves are biphasic, probably reflecting the G protein-coupled and uncoupled states of the receptor. The proportion of the high-affinity component is increased by GS39783, suggesting that the G protein coupling of the receptor is also promoted by the positive modulator. We also show that GS39783 has modulatory effects in cellular assays such as GABA B receptor-mediated activation of inwardly rectifying potassium channels in Xenopus oocytes and Ca 2ϩ signaling in human embryonic kidney 293 cells. In a more physiological context, GS39783 is shown to suppress paired pulse inhibition in rat hippocampal slices. This effect is reversed by the competitive GABA B receptor antagonist CGP55845A and is produced most likely by enhancing the effect of synaptically released GABA at presynaptic GABA B receptors.
The receptors for the major inhibitory neurotransmitter in the central nervous system, GABA, are subdivided into ionotropic GABA A receptors and metabotropic GABA B receptors. Whereas GABA A receptors form a chloride-permeable ion channel that elicits short-lasting inhibitory postsynaptic potentials, GABA B receptors are G-protein coupled receptors (GPCRs) that inhibit cyclic AMP formation and modulate the activity of inwardly rectifying potassium channels and voltage-sensitive calcium channels. By these mechanisms, they act post-and presynaptically to inhibit neuronal excitability (by producing a late, long-lasting component of inhibitory postsynaptic potentials) and neurotransmitter release, respectively. Whereas benzodiazepines are well established positive allosteric modulators of GABA A receptor function, the first examples of such allosteric enhancers for GABA B receptors have only recently been described (Urwyler et al., 2001) . As a therapeutic principle, positive modulators are expected to have several advantages over compounds acting as agonists, because they are only effective in the presence of the endogenous ligand and therefore act in line with physiological neurotransmission in its temporal and spatial organization. Agonists, on the other hand, activate receptors independently of synaptic activity, possibly leading to unwanted side effects. For these reasons, the search for pos-itive modulators not only for ionotropic receptors but also for GPCRs has recently attracted considerable interest (Pin et al., 2001; Christopoulos, 2002; Christopoulos and Kenakin, 2002) . In this study, we present a novel class of allosteric enhancers of GABA B receptors, GS39783 and some of its analogs (Fig. 1) . Furthermore, we also provide some new insights into the molecular and physiological mechanisms of allosteric GABA B receptor modulation.
Materials and Methods
Culture and the preparation of membranes of CHO cell clones stably expressing human GABA B(1b) /rat GABA B(2) were done as described in detail previously (Urwyler et al., 2001) . The preparation of rat brain cortical membranes for native receptor assays was also performed as described previously (Olpe et al., 1990) .
[ 35 S]GTP␥S Assay. The composition of the assay mixtures (in a final volume of 250 l in 96-well clear-bottom microtiter plates, Isoplates; PerkinElmer Wallac, Gaithersburg, MD) was as follows: 50 mM Tris-HCl buffer, pH 7.7, 10 mM MgCl 2 , 0.2 mM EGTA, 2 mM CaCl 2 , 100 mM NaCl, 10 M guanosine 5Ј-diphosphate (30 M with rat cortical membranes; Sigma-Aldrich, St. Louis, MO), 50 l of the membrane suspension (approximately 10 -20 g of protein), 1.5 mg wheat germ agglutinin-coated SPA beads (Amersham Biosciences UK, Ltd., Little Chalfont, Buckinghamshire, UK), 0.3 nM [ 35 S]GTP␥S (ca. 1,000 Ci/mmol, stabilized solution; Amersham Biosciences UK, Ltd.), and the test compounds at the appropriate concentrations. Nonspecific binding was measured in the presence of unlabeled GTP␥S (10 M; Sigma Chemical, Buchs, Switzerland). The samples were incubated at room temperature for 60 min, before the SPA beads were sedimented by centrifugation at 2,600 rpm for 10 min. The plates were then counted in a 1450 Microbeta liquid scintillation counter (PerkinElmer Wallac). For data analysis, nonspecific binding was subtracted from all the other values; the effects of GABA and modulators were expressed relative to basal activity, measured in the absence of agonist. Concentration-response curves were analyzed by nonlinear regression. Prism 3.0 software (GraphPad Software Inc., San Diego, CA) was used for all data calculations.
Radioligand Binding Experiments. The procedure to measure the binding of [ 3 H]CGP62349 to rat cortical membranes was based on that described by Bittiger et al. (1996) ; it was, however, conducted in the SPA format. The assay mixture in a final volume of 250 l contained 20 mM Tris-HCl buffer, pH 7.4, 118 mM NaCl, 4.7 mM KCl, 1.8 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 5 mM Dglucose, 1 nM [ 3 H]CGP62349, the test compounds at the desired concentrations, rat cortical membranes (ca. 15 g of protein), and 1.5 mg of wheat germ agglutinin-coated SPA beads (Amersham Biosciences UK, Ltd.). Nonspecific binding was assessed in the presence of 5 M CGP56999A. The samples were incubated for 90 min at room temperature, before being counted in a 1450 Microbeta liquid scintillation counter.
For kinetic experiments with the agonist radioligand [ 3 H]APPA (Hall et al., 1995) , incubation mixtures were made up in a total volume of 25 ml in the same buffer, containing rat brain cortical membranes at the same concentration, as described above for [ 3 H]CGP62349 binding experiments. For association experiments, the samples were preincubated for 15 min at room temperature with or without 30 M GS39783 before the addition of [ 3 H]APPA (3 nM). Aliquots (1 ml) were then withdrawn from the incubation mixture at different times for vacuum filtration through GF/B filters (What- jpet.aspetjournals.org man, Maidstone, UK), followed by rapid rinsing with 2 ϫ 5 ml of ice-cold incubation buffer. For dissociation experiments, the mixtures containing 3 nM [ 3 H]APPA (with or without 30 M GS39783) were preincubated for 40 min at room temperature to reach equilibrium, before L-baclofen (final concentration, 10 M) was added in 1.5 ml to initiate the dissociation of the radioligand from the receptor. Aliquots (1 ml) were withdrawn from the incubation mixture at different times after the addition of L-baclofen for separating bound and free radioligand by filtration as in the association experiments. In both types of experiments, nonspecific binding was determined in the presence of 10 M L-baclofen and measured in separate samples.
The results from radioligand binding assays (equilibrium displacement and kinetic experiments) were analyzed using standard procedures and GraphPad Prism software.
Measurement of Change in Intracellular Calcium Concentration by Fluorometry. For the measurement of changes in intracellular calcium concentrations, HEK293 cells were transiently transfected with human GABA B(1a/2) or GABA B(1b/2) . All transfections included G␣ qzic to couple GABA B receptors to PLC (Franek et al., 1999 ) and were made as described in detail previously (Pagano et al., 2001) . Transfected HEK293 cells were plated into poly-D-lysinecoated 96-well plates (BD Biosciences, San Jose, CA). Post-transfection (24 -72 h), cells were loaded for 45 min with 2 M fluo-4 AM (Molecular Probes, Eugene, OR) in Hanks' balanced salt solution (Invitrogen, Basel, Switzerland) containing 20 mM HEPES and 50 M probenecid (Sigma Chemical). Plates were washed and transferred to a fluorescence imaging plate reader (FLIPR; Molecular Devices, Crawley, UK). GS39783 was added 5 min before recording. Twenty seconds after the start of the readings, 0.3 M or 3 M GABA was added to all wells and their fluorescence was measured for 160 s. Relative fluorescence changes over baseline (⌬F/F) were determined. Concentration-response curves were recorded with four wells per concentration and experiment; the data were pooled and fitted using Igor Pro (Wavemetrics, Lake Oswego, OR) with a logistic equation using weighted nonlinear regression.
Oocyte Electrophysiology. Experiments were performed as described previously (Lingenhoehl et al., 1999) . Ovary lobes containing oocytes were removed surgically from anesthetized (1.2 g/l MS222; Sigma, Buchs, Switzerland) female Xenopus laevis frogs. Oocytes were separated and defolliculated and injected with 10 to 50 ng of cRNA of rat GABA B(1a) and GABA B(2) , together with inwardly rectifying potassium channel subunits Kir3.1, 3.2, and 3.4 (rat) . After incubation at 18°C for 3 to 8 days, two-electrode voltage-clamp recordings were done with a GeneClamp 500 amplifier (Axon Instruments, Union City, CA) using electrodes filled with 3 M KCl. Oocytes were continuously perfused with normal frog Ringer (115 mM NaCl, 10 mM HEPES, 2.5 mM KCl, and 1.8 mM CaCl 2 , pH 7.2) or highpotassium Ringer (90 mM KCl, 27.5 mM NaCl, 10 mM HEPES, and 1.8 mM CaCl 2 , pH 7.2). Recordings were performed at a clamp potential of Ϫ70 mV.
Measurement of Paired Pulse Inhibition. Semisubmerged hippocampal slices were used for extracellular recordings. Male Sprague-Dawley rats, weighing 170 to 180 g, were killed by decapitation under light isoflurane anesthesia. The brains were rapidly removed and immersed in artificial cerebrospinal fluid (124 mM NaCl, 2.5 mM KCl, 1.25 mM KH 2 PO 4 , 2.5 mM CaCl 2 , 2 mM MgSO 4 , 26 mM NaHCO 3 , and 10 mM glucose; 307 Ϯ 2 mOsM) at room temperature. The hippocampi were dissected and cut transversly into 400-m slices using a tissue chopper (Sorvall, Newton, CT). Slices were transferred to a rectangular interface chamber and kept at room temperature for 20 min; the temperature was then raised to 32°C. The artificial cerebrospinal fluid level was adjusted to just below the upper surface of the slices and the chamber was continuously supplied with a warmed, humidified 95% O 2 , 5% CO 2 mixture. The slices were left to equilibrate for a minimum of 1 h before starting the recordings.
Extracellular population spikes were recorded in the CA1 pyramidal cell layer. Drugs were administered by addition to the superfusion medium at a rate of 1 ml/min and were applied for a sufficient period (10 -20 min) to give their full effect before the start of the experiment. The recordings were made using glass microelectrodes (5-7 M⍀) filled with 4 M NaCl. Synaptic responses were evoked by stimulating the Schaffer collateral-commissural fibers in the stratum radiatum (orthodromic stimulation) using a bipolar stimulation electrode (twisted Pt/iridium wire; 25 m in diameter) and constant current stimuli (1.5-4.0 A; 100-s pulse width). GABAergic inhibitory circuits were studied using the paired-pulse inhibition paradigm at a fixed interstimulus interval of 20 ms delivered every 15 s. The amount of paired-pulse inhibition was determined by calculating the ratio of the amplitude of the population spike in response to the second stimulus (test pulse, U test ) to the amplitude of the population spike in response to the first stimulus (conditioning pulse, U cond ). Test and conditioning stimuli were of the same strength and adjusted so that the size of U cond was 90% maximal under control conditions. Records were captured and averaged (average of four responses) using an oscilloscope (LeCroy 9430; Le Croy SA, Geneva, Switzerland) and plotted on a Hewlett Packard plotter (HP 7475). Slices were accepted for experiments if the evoked maximum orthodromic population spike during the control period was at least 6 mV and free from multiple spikes.
Chemicals. GS39783 and its analogs were synthesized in house (Fischer, 1972 (Fischer, , 1974 (Fischer, , 1975 . Stock solutions were usually prepared in dimethyl sulfoxide and subsequently diluted in the respective assay buffers. The final dimethyl sulfoxide concentrations usually did not exceed 0.3% and did not interfere with the measured parameters. (Fig. 2) . Also, in the presence or in the absence of GS39783, no increase above basal levels was observed when the activation produced by GABA (1 M) was blocked by the competitive GABA B receptor antagonist CGP56999A (10 M; Fig. 2 ). In membranes from CHO cells stably expressing metabotropic glutamate receptor 2 instead of GABA B receptors, GS39783 did not enhance the stimulation of [ tions of GABA (1 and 20 M). It can be seen that the amplifying effect of GS39783 is observed with both recombinant (top) and native (bottom) GABA B receptor preparations, with very similar EC 50 values in the low micromolar range ( Fig. 3 ; Table 1 ).
Results

GS39783 Enhances the Stimulation of [
GS39783 Enhances Both Agonist Affinity and Efficacy at Recombinant GABA B(1b/2) Receptors in the [ 35 S]GTP␥S Assay. Concentration-response curves for GABA at different fixed concentrations of GS39783 reveal that a dual mechanism of GABA B receptor modulation results in an increase of both the potency (maximally about an 8-fold increase) as well as the maximal intrinsic efficacy (about a 2.2-fold increase) of GABA. These effects are dependent on the concentration of the positive modulator GS39783 ( Fig. 4 ; Table 2 ). The 8-fold increase in the potency of GABA produced by GS39783 represents the effect of a maximally active concentration of the modulator, compared with a control obtained with GABA alone. On the other hand, it is not possible to measure a potency of GS39783 in the absence of GABA, because the compound has no effect on its own. Therefore, the effects of GS39783 on GABA potency (Table 2) cannot be compared with the reciprocal effects of GABA on the potency of the modulator, obtained at two nonsaturating GABA concentrations (Table 1) .
Effects of GS39783 on Agonist Affinities and Kinetic Rate Constants in Radioligand Binding Assays. To determine the effects of GS39783 on the affinities of different agonists for native GABA B receptors, binding experiments with [
3 H]CGP62349 (a competitive antagonist radioligand) using membranes from rat brain cortex were performed. As shown in Fig. 5 , displacement curves obtained with GABA, L-baclofen, and APPA revealed enhanced affinities for all three agonists in the presence of 30 M GS39783. In all cases, a two-site model yielded a significantly better curve fit than a one-site model. As shown in Table 3 , the affinities of both the high-and low-affinity components of agonist binding were increased by 30 M GS39783. (It should be noted that the pK i value found for the high-affinity component of APPA was considerably higher than expected from that found earlier in saturation experiments (Urwyler et al., 2001 ). However, this is due to different assay conditions (the earlier Table 1 .
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experiments were conducted in the presence of 50 M GDP, which was omitted in the experiments shown here in Table 3 and Fig. 5. ) Furthermore, the relative proportion of high affinity sites was slightly, but consistently increased in all experiments in the presence of the modulator. If the percentages of high-affinity site values for all three agonists were pooled (assuming that high-and low-affinity receptor states are the same regardless of the agonist used), the means were 48 Ϯ 0.9% in the absence and 55 Ϯ 1.5% in the presence of 30 M GS39783 (p Ͻ 0.01, n ϭ 12 in each group).
In these experiments, the control specific binding of 1 nM Table 3 . Thus, it follows that GS39783 does not bind to the orthosteric ligand binding site and does not act by changing the total number of available GABA B receptors.
The high agonist-affinity state of the GABA B receptor can be directly labeled by the agonist radioligand [ 3 H]APPA. We made use of this possibility to determine the effects of GS39783 on the rates of association and dissociation of this agonist at native GABA B receptors (Fig. 6) . In association experiments, as expected, the level of binding once equilibrium was reached was higher in the presence of the modulator than in its absence (top, inset), due to the increased affinity for APPA. However, somewhat unexpectedly, the rate of association was slower in the presence of 30 M GS39783. This effect was overcompensated by an even greater decrease in the rate of dissociation produced by the modulator, the net effect thus resulting in an increased binding affinity of [ 3 H]APPA, as is reflected in the K d values, which can be calculated from the different rate constants given in Table 4 . Table 2 for a summary of the results from several independent experiments. Table 3 . GABA B(1b/2) and cotransfected with G␣ qzic to couple GABA B receptors to PLC, GABA elicited a transient calcium signal (Fig. 7, inset) . Thus, as observed previously with CGP7930 in Xenopus oocytes (Urwyler et al., 2001) , this effect of GS39783 was not dependent on the GABA B(1) receptor isoform. At a low (0.3 M) and at a higher (3 M) concentration of GABA, the signal was potentiated in a concentration-dependent manner by GS39783 (Fig. 7) . Like in the [
35 S]GTP␥S assay, the signal measured in the presence of GS39783 clearly exceeded the maximal effect produced by GABA on its own. Table 5 gives the corresponding EC 50 values and maximal effects of GS39783 under the different conditions used. GS39783, when applied in the absence of GABA, did not produce any calcium signal on its own (Fig. 7) .
GS39783 Enhances the Effects of GABA on Inwardly Rectifying Potassium Channels in Xenopus Oocytes.
The effects of GS39783 on the regulation of inwardly rectifying potassium channels via GABA B receptors in Xenopus oocytes is shown in Fig. 8 . Exposure of the oocytes to a high potassium (90 mM) Ringer solution elicited an inward current that was reversibly amplified in the presence of GABA. The effect of a low concentration (0.3 M, ϳEC 20 value) of GABA was increased in the presence of GS39783 (Fig. 8, top) . Upon adding 10 M GS39783 to ascending concentrations of GABA, a left-shift in the GABA concentration-response curve [EC 50 ϭ 1 M (95% confidence interval: 0.58 -1.74 M), compared with 1.63 M (95% confidence interval: 1.34 -1.98 M) for the control curve] and an increase in the maximal GABA response to 127 Ϯ 5 (S.E.M.) percentage of the control value were observed (Fig. 8, bottom) . No intrinsic agonistic activity of GS39783 was seen in oocytes (data not shown).
GS39783, Like L-Baclofen, Reduces Paired-Pulse Inhibition in Hippocampal Slices. In a hippocampal slice preparation, the application of two consecutive stimuli to afferent pathways results in inhibition of the second population response. In our experiments, addition of Lbaclofen (1 M) completely suppressed paired pulse inhibition (U test /U cond. ϭ 0.36 Ϯ 0.08 for controls and 1.07 Ϯ 0.09 in the presence of baclofen; mean Ϯ S.E.M., n ϭ 8, p Ͻ 0.01; recordings not shown). This effect of L-baclofen was reversed in the presence of the competitive antagonist CGP55845A (3 M; data not shown). A similar reduction of paired pulse inhibition was produced by 10 M GS39783 (Fig. 9) ; in fact, the ratio U test /U cond. was 0.36 Ϯ 0.03 in the absence and 0.90 Ϯ 0.1 in the presence of 10 M GS39783 (n ϭ 4; p ϭ 0.01). This effect was also antagonized by 3 M CGP55845A (Fig. 9) . The kinetic experiments were performed in the absence (F) and in the presence (f) of 30 M GS39783 as described under Materials and Methods. Because of the increased affinity of the agonist radioligand, equilibrium binding is higher in the presence of GS39783. To make the effect of GS39783 on the rate of association more visible, the data shown in the top are normalized to the level of equilibrium; the actual cpm values are given in the inset. Because aliquots were drawn for filtration at different times from a single incubation mixture, only single data points are available for each time. The kinetic constants derived from three independent experiments are given in Table 4.   TABLE 3 Effects of GS39783 on the affinities of agonists for native GABA B receptors from rat cortical membranes in radioligand binding assays
The binding of ͓ 3 H͔CGP62349 to membranes from rat brain cortex was measured as described under Materials and Methods. Inhibition curves with the three agonists shown as displacers were constructed as illustrated in Fig. 5 
Discussion
Only recently, the first allosteric enhancers of GABA B receptor function, CGP7930 and CGP13501, have been described (Urwyler et al., 2001 ). Three arylalkylamine derivatives have meanwhile also been reported to enhance GABA B receptor-mediated responses in rat cortical slices (Kerr et al., 2002) . However, in that report molecular mechanisms of action were not addressed. Two of these compounds were found to be totally inactive in our biochemical assays (S. Urwyler, T. Gjoni, K. Kaupmann, M. F. Pozza, and J. Mosbacher, manuscript in preparation). In the present study, we introduce for the first time a novel structure, GS39783 (Fig.  1) , with the pharmacological characteristics of an allosteric GABA B receptor modulator. Some analogs of this compound ( Fig. 1) have also been found to amplify GABA B receptormediated responses; however, GS39783 was the most efficacious modulator in this series (Fig. 2) .
The actions of GS39783 are very similar to those of the previously described compound CGP7930 (Urwyler et al., 2001) 
in [
35 S]GTP␥S binding and cellular assays (intracellular calcium release, effects on Kir3 channels in Xenopus oocytes). In these experiments, GS39783 had no effect without the concomitant activation of the orthosteric ligand binding site by an agonist, but potentiated the effects of agonists, and the maximal effects of GABA in the presence of the modulator exceeded those of GABA at a saturating concentration alone (Figs. 3, 4 , 7, and 8). However, although the potencies of the two compounds (in terms of EC 50 values; Tables 1 and 5 ) are very similar, GS39783 seems to be more efficacious than CGP7930 in enhancing GABA B receptormediated responses. In fact, the maximal stimulation of [ 35 S]GTP␥S binding by GABA was increased to about 200% of control at maximally active concentrations of GS39783 (Table 2) , whereas with CGP7930 only about a 40% increase was obtained (Urwyler et al., 2001 ). On the other hand, at the highest concentration tested, GS39783 increased the potency of GABA by an 8-fold, whereas a maximally 6-fold increase was obtained previously with CGP7930. Thus, like CGP7930, GS39783 acts through a dual mechanism, by enhancing at the same time the affinity and the maximal efficacy of GABA. This mode of action seems unusual compared with that of previous examples of allosteric modulators at other GPCRs, which affect only agonist potencies but not the maximal FLIPR experiments on HEK293 cells transiently transfected with human GABA B(1a/2) or GABA B(1b/2) and cotransfected with G␣ qzic to couple the receptors to the PLC pathway were performed as described under Materials and Methods. Concentration-response curves for GS39783 were constructed at two different GABA concentrations as illustrated in Fig. 7 for GABA B(1a/2) . The data shown are means Ϯ S.E.M. from n independent experiments. (Table 5) . responses. However, recently at least two other examples of allosteric enhancers have become known, which increase the affinities as well as the intrinsic efficacies of agonists at glutamate metabotropic glutamate receptor 1 (Knoflach et al., 2001 ) and adenosine A3 receptors (Gao et al., 2002) . This mechanism of allosteric modulation is accounted for by a recently developed theoretical model (Hall, 2000) . The allosteric effects of GS39783 on native and recombinant GABA B receptors were further corroborated in radioligand binding experiments. The effects of the previously described GABA B receptor modulator CGP7930 on the displacement of [ 3 H]CGP62349 by GABA in recombinant receptor preparations were found to be complex due to the lack of sensitivity of the overexpressed GABA B(1) monomer to the allosteric effects of this compound (Urwyler et al., 2001) . For this reason, we have chosen to use native receptors for this type of experiment in this study. Agonist displacement curves were biphasic (Fig. 5) , presumably due to the presence of GABA B receptors coupled to and uncoupled from their G proteins. In fact, it is well known that GABA B receptors, like most GPCRs, have different agonist affinities in these two different states (Hill et al., 1984; Parmentier et al., 2002) . Interestingly, the affinities of both receptor forms for agonists were significantly enhanced by GS39783 (Table 3 ; Fig.  5 ). Moreover, the relative proportion of the high-affinity state was increased to some extent by GS39783, strongly suggesting that the coupling of the receptor to its G proteins was also promoted by this compound. This mechanism might well contribute to the finding that the maximal efficacy of GABA B receptor activation was enhanced by the positive modulator.
Recombinant
A reliable and widely used method to demonstrate and quantify allosteric effects is kinetic (nonequilibrium) radioligand binding experiments (Christopoulos and Kenakin, 2002) . The rate constants of association and dissociation of an orthosteric ligand are very sensitive to changes in receptor conformation induced by an allosteric ligand. In particular, whereas the rate of association can also be decreased by conventional competitive agents, the dissociation is a zeroorder reaction and is most indicative of such a conformational change induced by another agent acting at a distant site. It is the balance of the changes in kinetic association and/or dissociation rate constants that makes up the effects of allosteric modulators on orthosteric ligand affinity at equilibrium. Thus, a positive modulator could enhance agonist affinity by enhancing the rate of association or reducing the rate of dissociation of an agonist, or both. In our experiments, how- In the presence of 3 M GS39783 (gray column), the response to 0.3 M GABA is enhanced. Bottom, concentration-response curves for GABA in the absence (f) and in the presence of 10 M GS39783 (Ⅺ). GS39783 caused a left shift of the GABA concentration-response curve and an increase in the maximal response amplitude. All values were normalized to a 100 M GABA response (Io) that was measured on every oocyte. The values shown are means Ϯ S.E.M. from at least three different oocytes. ever, GS39783 reduced the rate of association of [ 3 H]APPA to native GABA B receptors, but this effect was overcompensated by an even greater reduction in its rate of dissociation, resulting in a net increase of affinity for this agonist radioligand. It is of interest in this context that, although an increase of association rate could theoretically be the underlying mechanism of action of a positive allosteric modulator, to date no such mechanism seems to have been conclusively shown for any GPCR (Holzgrabe and Mohr, 1998; Christopoulos and Kenakin, 2002) .
In a hippocampal slice preparation, the application of two consecutive stimuli to afferent pathways results in inhibition of the second population response, due to the activation of local inhibitory GABAergic interneurons (Alger and Nicoll, 1982) . Therefore, paired-pulse inhibition provides a reliable measure of GABA receptor-mediated synaptic inhibitory function. Activation of presynaptic GABA B receptors leads to a suppression of this paired pulse synaptic inhibition, most likely through inhibition of GABA release from interneurons (Deisz and Prince, 1989; Thompson and Gaehwiler, 1989) . Thus, in our experiments, 1 M L-baclofen completely suppressed paired pulse inhibition; upon coapplication of the competitive GABA B receptor antagonist CGP55845A (Davies et al., 1993) , this effect of baclofen was completely reversed (data not shown). The positive modulator GS39783, on its own, had an effect similar to that of the agonist baclofen (Fig.  9) . However, because our other assays have shown that the compound does not directly activate the GABA B receptor on its own, its suppression of paired pulse inhibition is most likely due to modulation of the effects of endogenous GABA. The finding that the competitive antagonist CGP55845A reversed the effect of GS39783 is in line with this interpretation. In fact, a competitive antagonist would not be expected to inhibit GABA B receptor activation by a compound acting at a different site than GABA, if any agonistic activity by GS39783 were to be present.
In conclusion, GS39783 has been shown to act as a positive allosteric modulator at native and recombinant GABA B receptors in different in vitro assay systems. A key question that remains to be answered is certainly that of whether the two structurally different positive modulators CGP7930 and GS39783 exert their effects through the same or through distinct allosteric sites on the GABA B receptor. Parmentier et al. (2002) have recently suggested that allosteric modulators of family 3 GPCRs act through their seven transmembrane domains; however, in the case of the GABA B receptor this hypothesis awaits experimental confirmation.
